FactaeThe Factual News

Ipsen completes acquisition of Kartos Therapeutics

Pharmaceutical group Ipsen announces the definitive acquisition of Kartos Therapeutics.

Published 1j1 sourceNotableupdated 1j
Lire en français
≈ 13s

The fact

This deal strengthens its portfolio in innovative oncology therapies.

Kartos Therapeutics specializes in blood cancer treatments.

Click the link to read an article on the topic:
Explore this topic
What if you saw the whole news differently?Factae cross-checks hundreds of sources worldwide to keep only the fact, no opinion. Explore the front page.
FranceWorld map →
Follow topic →
Auto-synthesis from 1 media source · identified on August 21, 2026
← Back to home
Discover

Read more

All marches →
marches450 million

Ipsen acquires Kartos Therapeutics for $450 million

7sem · 1 sourcemarches

Ipsen completes acquisition of Memo Therapeutics AG

4sem · 1 sourcemarches

Ipsen prepares acquisitions with a 2 billion euro fund

3sem · 1 sourcemarches

Ipsen maintains intact bullish signals in market

18sem · 1 sourcemarches

Ipsen releases positive new data from phase III Elative trial

12sem · 1 source